Skip to main content

Vol. 2026 · Bill Detail · Special Edition

CivicRadar.

Wednesday, September 2, 2026

Free · Stays on your device

ME · LD1847FINAL · 9 COSPONSORS

An Act to Institute Testing and Tracking of Medical Use Cannabis and Cannabis Products Similar to Adult Use Cannabis and Cannabis Products, Dedicate a Portion of the Adult Use Cannabis Sales and Excise Tax to Medical Use Cannabis Programs and Create a Study Group

Where it is in the process
Plain-English Summary

This bill creates a new program to test and track cannabis and cannabis products used for medical purposes, similar to rules for adult-use cannabis. It requires dispensaries and caregivers to submit products for testing to ensure they are safe and correctly labeled before selling them to patients. The bill also sets limits on THC potency and requires tracking of cannabis from plant to sale.

No official summary on file for this bill · generated by Gemini 2.5 Flash from its full text

Votes
Sponsorship · 10 Sponsors
Democrat9Republican1Independent0Other0
  • D · PrimeAnne Graham
  • D · CoSean Faircloth
  • D · CoLori Gramlich
  • D · CoHenry Ingwersen
  • D · CoMichele Meyer
  • R · CoMarianne Moore
  • D · CoCameron Reny
  • D · CoDaniel Shagoury
  • D · CoDenise Tepler
  • D · CoSamuel Zager
Read full bill text →↓ Why am I seeing this?

Want updates?

Get notified when ME LD1847 moves stage

Pick a channel below. Every option is opt-in, and we tell you exactly what we store.

Email

Identified

We store your email address and the bill ID. We'll send a confirmation link first; alerts only start after you click it. Every email has a one-click unsubscribe.

Coming soon

  • RSS feed· Atom 1.0 + JSON Feed per bill
  • Bluesky· follow a CivicRadar bot post per status change
  • Telegram· channel or DM via bot
  • Discord· channel webhook
  • WhatsApp· via WhatsApp Business
  • SMS· via Twilio